Authors
Melnichenko V.Y. 1, Fedorenko D.A.1, Ionova T.I.1, 2
1 Pirogov National Medical and Surgical Center, Moscow
2 Clinic of High Medical Technologies named after N.I. Pirogov, Saint-Petersburg State University Hospital, Saint-Petersburg
Abstract
The main stages of the development of A.A. Maximov hematology department are presented. The analysis of modern trends of hematology research and clinical medicine is provided, the core achievements in the field in hematology are described.
Keywords: hematology, A.A. Maximov department of hematology.
References
1. Novik AA, Bogdanov AN. Anemii (ot A do Y). Rukovodstvo dla vrachey. Akad. RAMN Y.L Shevchenko, editor. Spb.: Neva, 2004. 320 р. (In Russ.)
2. Novik A.A. Ionova T.I. Issledovanie kachestva zizni v medicine, Uchebnoe posobie dla vuzov. Y.L. Shevchenko, editor. M.: GEOTAR-MED, 2004. 304 р. (In Russ.)
3. Novik A.A., Kamilova T.A., Cigan V.N. Vvedenie v molecularnuyu biologiy cancerogeneza: Uchebnoe posobie. Y.L. Shevchenko, editor. M.: GEOTAR-MED, 2004. 224 р. (In Russ.)
4. Novik A, Ionova T, Bisaga G, Kishtovich A, Fedorenko D, Ivanov R, Gorodokin G. Clinical and Quality of life responses to high-dose chemotherapy plus autologous stem cell transplantation in patients with multiple sclerosis: two case reports. Cytotherapy. 2005; 7(4): 363-367.
5. Novik AA, Ivanov RA. Kletocnaya terapya. M.:MIA, 2007. (In Russ.)
6. Novik AA, Kuznetsov AN, Melnichenko VY, Fedorenko DA, Ionova TI, Gorodokin GV. Non-myeloablative Autologous Haematopoietic Stem Cell Transplantation with Consolidation Therapy using Mitoxantrone as a Treatment Option in Multiple Sclerosis Patients. J Stem Cell Res Ther. 2011; 1:1. doi: 10.4172/2157-7633.1000102.
7. Shevchenko YL, Novik AA, Kuznetsov AN, Fedotov JN, Melnichenko VY, Fedorenko DA, Kruglina RV, Kartashov AV, Ionova TI, Rainov JI, Kurbatova KA. Autologous hematopoietic stem cell transplantation for multiple sclerosis: results of the Russian cooperative group for cellular therapy. 2010; XLVI, 1-2: 18-27.
8. Put poznania dolog, zizni corotka. Vospominania o Andree Arcadieviche Novike. Аcademic RAMN Y.L. Shevchenko, editor. Sost. TI. Ionova. Spb.: MCICZ, 2012. 344р. il. (In Russ.)
9. Guidelines. Patient-reported outcomes in hematology. Editors: A. Novik, S. Salek, T. Ionova. Genoa: Forum service editore. 2012. 203 p.
10. Shevchenko YL, Kuznetsov AN, Ionova TI, Melnichenko VY, Fedorenko DA, Kartashov AV, Kurbatova KA, Gorodokin GI, Novik AA. Autologous Haematopoietic Stem Cell Transplantation with Reduced Intensity Conditioning in Multiple Sclerosis. Experimental Hematology. 2012; 40(11): 892-898.
11. Shevchenko YL, Kuznetsov AN, Ionova TI, Melnichenko VY, Fedorenko DA, Kurbatova KA, Gorodokin GI, Novik AA. Long-term outcomes of autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis: physician’s and patient’s perspectives. Annals of Hematology. 2015; 94(7): 1149-1157.
12. Novik AA, Ionova TI. Guidelines on quality of life research in medicine. 4th ed., updated and supplemented. Yu.L. Shevchenko, editor. M.: Pirogov National Medical Surgical Center; 2021. (In Russ).
13. Passweg JR, Baldomero H, et al. 30 Years EBMT ACTIVITY SURVEY and 2019 annual report. Bone Marrow Transplantation, Jan 2021.
